Nurix Therapeutics (NRIX) Stock Forecast & Price Target

NRIX$15.48-0.12 -0.77%
BiotechnologyValue StockGrowth StockHigh Quality
Compare
Market cap$1.69BEnterprise value$2.22BRevenue (TTM)$701.94MMarket position—

Score

85
Bullish
Value
69
Quality
97
Growth
90

Nurix Therapeutics, Inc. price target

NRIX
Low$31.00
Average$35.58
High$45.00
Upside vs current price+129.8%

The average target of $35.58 is +129.8% versus the current NRIX price of $15.48.

Nurix Therapeutics, Inc. analyst ratings

RatingAnalysts
Strong buy5
Buy8
Hold1
Sell0
Strong sell0
ConsensusBuy

14 analysts cover NRIX.

Nurix Therapeutics, Inc. EPS and revenue estimates

NRIX shows the next fiscal years with at least three analysts: 2026 EPS $2.35, 2027 EPS $-2.13. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$2.35$681.79M
2027$-2.13$99.61M

Is Nurix Therapeutics, Inc. a buy or sell?

Of the 14 analysts covering Nurix Therapeutics, Inc., 13 rate it a buy (5 strong buy and 8 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The NRIX consensus label is Buy, beside 13 buy-side ratings and 0 sell-side ratings.

The average target of $35.58 implies +129.8% versus the current price of $15.48.

Those 14 ratings on NRIX are a headcount, and the label on file is Buy.

Reading the Nurix Therapeutics, Inc. forecast

The NRIX target band runs from $31.00 to $45.00. The average inside that band is $35.58.

Set next to the $15.48 NRIX quote, that average is +129.8%.

Ratings on the Nurix Therapeutics, Inc. cluster: 13 of 14 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.

NRIX targets have not moved much: $35.50 recently, $35.50 across the quarter.

Only 14 analysts cover NRIX, so the average rests on a short list.

Nurix Therapeutics, Inc. forecast questions

What is the NRIX price target?

The published range for NRIX is $31.00 to $45.00, with an average of $35.58. That average is +129.8% versus the current price of $15.48.

Is Nurix Therapeutics, Inc. a buy or sell?

Of the 14 analysts covering Nurix Therapeutics, Inc., 13 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, and the NRIX headcount is 13 buy, 1 hold, and 0 sell.

What is the EPS estimate for Nurix Therapeutics, Inc.?

Analyst EPS estimates for Nurix Therapeutics, Inc.: 2026 $2.35, 2027 $-2.13.

What is the revenue estimate for Nurix Therapeutics, Inc.?

Analyst revenue estimates for Nurix Therapeutics, Inc.: 2026 $681.79M, 2027 $99.61M.

How many analysts cover NRIX?

14 analysts cover NRIX. Their consensus on NRIX is Buy, across those 14.

NRIX price $15.48 -0.12 -0.77%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener